Market Tracker

10/31 11:43am ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

12.47
Real-Time Quote
 +0.35 / +2.89%
Today’s Change
5.70
Today|||52-Week Range
19.25
+0.48%
Year-to-Date

Today’s Trading

Previous close12.12
Today’s open12.43
Day’s range12.11 - 12.57
Volume362,110
Average volume (3 months)646,329
Market cap$471.5M
Dividend yield--
Data as of 11:28am ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+31.63%
Earnings growth (this year)-196.27%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+3.52%
P/E ratioNM
Price/Sales11.12
Price/Book9.16

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.39-1.99%
VSARVersartis Inc+0.25+1.25%
ZFGNZafgen Inc+0.03+0.14%
XOMAXOMA Corp-0.11-2.30%
Data as of 11:41am ET, 10/31/2014

Financials

Last reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$33.9M
Annual profit (last year)-$20.3M
Net profit margin-59.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts